Skip to content

Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study

Compassionate Use Study of the Bion for Occipital Nerve Stimulation for Treatment of Chronic Headaches

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01050959
Enrollment
11
Registered
2010-01-18
Start date
2010-01-31
Completion date
2011-04-30
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic, Medically Refractory Headache

Brief summary

The purpose of this compassionate use study is to provide clinical and technical support of the Bion® microstimulator system to the subjects who have decided to keep the system for relief of headache symptoms that have not responded to medical treatment. These study subjects were enrolled and implanted with the Bion® system during a previous clinical investigation of the Bion® for occipital nerve stimulation (ONS) in the United States.

Interventions

DEVICEbion

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject participated in a prior clinical feasibility study of the Bion for occipital nerve stimulation in the treatment of chronic headaches (IDE G030225) and remained implanted with the Bion system. * Subject elects to enroll in this compassionate use study and provides written informed consent. * Subject understands the type and duration of clinical, technical or product support provided in the study. * Subject is willing to comply with protocol-required activities.

Exclusion criteria

* Subject is currently participating or intends to participate in another investigational drug or device clinical trial for chronic headaches during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Provision of one year of clinical and technical supportThis is a compassionate use study. There are no primary outcome measures.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026